The role of renal dopamine and PGE2 in mediating the renal effects of the antihypertensive loop diuretic piretanide.
D015232:Dinoprostone; D004231:Diuresis / Q000187:drug effects; D004232:Diuretics / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism; D008138:Loop of Henle / Q000187:drug effects; D008297:Male; D009318:Natriuresis / Q000187:drug effects; D011339:Probenecid / Q000494:pharmacology; D011458:Prostaglandins E / Q000378:metabolism*; D013449:Sulfonamides / Q000494:pharmacology*
D004232:Diuretics; D011458:Prostaglandins E; D013449:Sulfonamides; C015451:piretanide; D015232:Dinoprostone; D011339:Probenecid; D004298:Dopamine; D007213:Indomethacin